| 000 | 01868 a2200553 4500 | ||
|---|---|---|---|
| 005 | 20250517232511.0 | ||
| 264 | 0 | _c20190114 | |
| 008 | 201901s 0 0 eng d | ||
| 022 | _a1735-546X | ||
| 024 | 7 |
_a10.22037/uj.v0i0.4326 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aUchida, Junji | |
| 245 | 0 | 0 |
_aEffect of Age on Conversion to Everolimus with Calcineurin Inhibitor Minimization at A Late Post-Transplant Stage. _h[electronic resource] |
| 260 |
_bUrology journal _c09 2018 |
||
| 300 |
_a266-271 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aCalcineurin Inhibitors _xadministration & dosage |
| 650 | 0 | 4 |
_aDrug Substitution _xmethods |
| 650 | 0 | 4 |
_aEverolimus _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGlomerular Filtration Rate |
| 650 | 0 | 4 |
_aGraft Rejection _xprevention & control |
| 650 | 0 | 4 |
_aGraft Survival _ximmunology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aJapan |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
| 650 | 0 | 4 |
_aKidney Transplantation _xmethods |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOutcome Assessment, Health Care |
| 650 | 0 | 4 | _aROC Curve |
| 650 | 0 | 4 |
_aTransplant Recipients _xstatistics & numerical data |
| 700 | 1 | _aNishide, Shunji | |
| 700 | 1 | _aKabei, Kazuya | |
| 700 | 1 | _aShimada, Hisao | |
| 700 | 1 | _aKosoku, Akihiro | |
| 700 | 1 | _aIwai, Tomoaki | |
| 700 | 1 | _aKuwabara, Nobuyuki | |
| 700 | 1 | _aNaganuma, Toshihide | |
| 700 | 1 | _aKumada, Norihiko | |
| 700 | 1 | _aTakemoto, Yoshiaki | |
| 700 | 1 | _aNakatani, Tatsuya | |
| 773 | 0 |
_tUrology journal _gvol. 15 _gno. 5 _gp. 266-271 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.22037/uj.v0i0.4326 _zAvailable from publisher's website |
| 999 |
_c28720351 _d28720351 |
||